Dr. Seyed MohamadMehdi Moshtaghion | Cabimer | Spain
Seyed MohamadMehdi Moshtaghion, MD, MSc, is a physician-scientist and Senior Research Technologist specializing in advanced therapies and diagnostic biomarkers for retinal degenerative diseases, with a primary focus on retinitis pigmentosa and age-related macular degeneration. His research integrates molecular biology, stem cell–based strategies, gene therapy, and artificial intelligence–driven retinal imaging to advance early diagnosis and personalized treatment approaches for vision-threatening disorders. He holds a medical degree from Shahid Beheshti University and advanced postgraduate training in biomedical investigation and molecular biology and biomedicine from the University of Seville, along with certification in animal experimentation. Dr. Moshtaghion has conducted research at leading international institutions, including Massachusetts Eye and Ear at Harvard Medical School, Karolinska Institutet, and CABIMER, contributing to translational projects that bridge laboratory discoveries with clinical ophthalmology. He has authored over 20 peer-reviewed scientific publications, with a total of 183 citations, an h-index of 8, and an i10-index of 8, reflecting consistent scholarly impact in the fields of retinal biology and regenerative medicine. His work has been presented at major international conferences such as ARVO and EURETINA, highlighting innovative therapeutic strategies and biomarker discovery in retinal disease research.
Citation Metrics (Google Scholar)
Citations
Documents
h-index
View Google Scholar Profile
Featured Publications